HPE vs KNSA · P/E 20, rev $32.19B vs P/E 53, rev $677.6M
Hewlett Packard Enterprise Co (HPE) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
Hewlett Packard Enterprise Co (HPE) is a communication equipment company listed on US.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported HPE revenue for 2026-07-31 was $32.19B. Net income was $2.62B. Revenue was up 61.1% from 2026-04-30 to 2026-07-31. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
HPE currently screens at market cap $27.19B and trailing P/E 19.9. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the HPE and KNSA stock pages for the full models.
Not investment advice.